Comparison of Generic Dasatinib Versus Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia with Reference to Early Molecular Response: Results from a Single-Center, Randomized Controlled Study from India
In: Blood, Jg. 140 (2022-11-15), S. 9640-9642
Online
unknown
Zugriff:
Titel: |
Comparison of Generic Dasatinib Versus Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia with Reference to Early Molecular Response: Results from a Single-Center, Randomized Controlled Study from India
|
---|---|
Autor/in / Beteiligte Person: | Sashi Kant Singh ; Kumar, Karthik ; Nayak, Jhasaketan ; Porwal, Jasmine ; Morang, Sikha ; Dhingra, Gaurav ; Uttam Kumar Nath |
Link: | |
Zeitschrift: | Blood, Jg. 140 (2022-11-15), S. 9640-9642 |
Veröffentlichung: | American Society of Hematology, 2022 |
Medientyp: | unknown |
ISSN: | 1528-0020 (print) ; 0006-4971 (print) |
DOI: | 10.1182/blood-2022-158786 |
Schlagwort: |
|
Sonstiges: |
|